Nothing Special   »   [go: up one dir, main page]

Roychowdhury et al., 2018 - Google Patents

Hydroponic treatment of Nicotiana benthamiana with kifunensine modifies the N-glycans of recombinant glycoprotein antigens to predominantly Man9 high-mannose …

Roychowdhury et al., 2018

View HTML
Document ID
12064355488106331302
Author
Roychowdhury S
Oh Y
Kajiura H
Hamorsky K
Fujiyama K
Matoba N
Publication year
Publication venue
Frontiers in plant science

External Links

Snippet

Nicotiana benthamiana transient overexpression systems offer unique advantages for rapid and scalable biopharmaceuticals production, including high scalability and eukaryotic post- translational modifications such as N-glycosylation. High-mannose-type glycans (HMGs) of …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)

Similar Documents

Publication Publication Date Title
Roychowdhury et al. Hydroponic treatment of Nicotiana benthamiana with kifunensine modifies the N-glycans of recombinant glycoprotein antigens to predominantly Man9 high-mannose type upon transient overexpression
Siriwattananon et al. Plant-produced receptor-binding domain of SARS-CoV-2 elicits potent neutralizing responses in mice and non-human primates
Vamvaka et al. Rice endosperm produces an underglycosylated and potent form of the HIV‐neutralizing monoclonal antibody 2G12
Lai et al. Structural and functional characterization of an anti‐West Nile virus monoclonal antibody and its single‐chain variant produced in glycoengineered plants
Fischer et al. Commercial aspects of pharmaceutical protein production in plants
D’Aoust et al. Influenza virus‐like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice
US10272148B2 (en) Chimeric influenza virus-like particles comprising hemagglutinin
RU2567012C2 (en) Method of producing plant protein
EP1799813B1 (en) System and method for production of antibodies in plant cell culture
Margolin et al. Production and immunogenicity of soluble plant-produced HIV-1 subtype C envelope gp140 immunogens
Singh et al. Expression of rabies glycoprotein and ricin toxin B chain (RGP–RTB) fusion protein in tomato hairy roots: a step towards Oral vaccination for rabies
Phakham et al. Functional characterization of pembrolizumab produced in Nicotiana benthamiana using a rapid transient expression system
Massa et al. Bioproduction of a therapeutic vaccine against human papillomavirus in tomato hairy root cultures
Margolin et al. A roadmap for the molecular farming of viral glycoprotein vaccines: engineering glycosylation and glycosylation-directed folding
So et al. Glycomodification and characterization of anti-colorectal cancer immunotherapeutic monoclonal antibodies in transgenic tobacco
CN116218900A (en) Increasing yield of virus-like particles in plants
Massa et al. Engineering plants for the future: farming with value-added harvest
US10066238B2 (en) Methods for producing antibodies
Margolin et al. Site-specific glycosylation of recombinant viral glycoproteins produced in Nicotiana benthamiana
Zahmanova et al. Green biologics: harnessing the power of plants to produce pharmaceuticals
Bulaon et al. Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer
Lotter-Stark et al. Plant made anti-HIV microbicides—a field of opportunity
Matoba N-glycosylation of cholera toxin B subunit: serendipity for novel plant-made vaccines?
Scotti et al. Plant-based anti-HIV-1 strategies: vaccine molecules and antiviral approaches
Rosenberg et al. Enhanced HIV SOSIP envelope yields in plants through transient co-expression of peptidyl-prolyl isomerase b and calreticulin chaperones and ER targeting